Institutional review board approval was obtained. Data collected included prepregnancy weight, BMI, and gestational weight gain (GWG), as well as tobacco and marijuana use. GWG was categorized according to Institute of Medicine and American College of Obstetricians and Gynecologists recommendations as adequate, inadequate, or excessive.RESULTS: A total of 7,653 patients were included in the study. Polysubstance use was excluded. Overall, 52% of patients experienced excessive GWG, 28% adequate GWG, and 19% inadequate GWG. Former tobacco users were more likely to have excessive GWG than non-smokers and current tobacco users (61% versus 51% and 51%; P,.001), while current tobacco users were more likely to have inadequate GWG than non-users and former tobacco users (24% versus 19% and 15%; P,.001). Marijuana users were more likely to have excessive GWG than non-users (57% versus 52%; P5.007). Marijuana use remained a significant predictor of excessive GWG, even when controlling for tobacco use (P,.035).CONCLUSION: It appears that tobacco and marijuana use may play a role in GWG. Further research is needed in order to fully understand and appropriately counsel on the potential effects of marijuana and tobacco use on GWG and pregnancy outcomes.
INTRODUCTION:Preliminary research indicates prenatal and postpartum care decreased during the COVID-19 pandemic. Models also indicate increases in unintended pregnancies after 2020. The goal of this study was to assess whether immediate postpartum long-acting reversible contraception (IPP LARC) insertions and desire for IPP LARC increased during COVID-19 among patients insured under TennCare Medicaid (TennCare or CoverKids) with access to coverage for this type of contraception.METHODS:Deliveries in patients insured under TennCare Medicaid Programs (n=6,922) in one East Tennessee hospital were assessed before and during the COVID-19 pandemic (January 2019 to May 2020 and June 2020 to December 2021, respectively). Data from electronic health records were securely collected in Excel and analyzed using SPSS software. Comparisons were made using chi-square tests.RESULTS:During COVID, increased uptake of IPP LARC was statistically significant: 18.0% (CI 16.9–19.1%) before the COVID-19 pandemic and 22.0% (CI 20.6–23.3%) during (P<.001). In addition, desire for IPP LARC increased significantly among patients: 20.0% (CI 19.1–21.3%) before COVID-19 and 22.3% (CI 21.0–23.7%) during COVID-19 (P=.016). Significant increases in desire for IPP LARC during the pandemic occurred among adolescent patients (<20 years of age) (P=.003), those living HRSA-defined nonrural areas (P=.024), non-Hispanic women (P=.036), and White women (P=.027).CONCLUSION:IPP LARC is a highly effective, convenient contraception option for women, especially during times with possible increased limitations in accessing postpartum care. Perhaps because of shelter-at-home orders, limitations in “nonessential” health care being practiced, or personal preferences and desires during the pandemic, IPP LARC was more highly utilized and desired by those wishing to avoid unintended pregnancy after the pandemic began.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.